| |
Type |
 G Protein-coupled receptors
|
|
|
Ion channels
|
|
|
Nuclear receptors
|
|
|
Protein kinases
|
|
|
Cytokines and receptors
|
|
|
Cell surface molecules and ligands
|
|
|
Transporters
|
|
|
 Enzymes
|
Oxidoreductases (EC1)
|
Dehydrogenases [EC:1.1.1.-]
|
Dehydrogenases [EC:1.2.1.-]
|
Dehydrogenases [EC:1.3.-.-]
|
Amine oxidases [EC:1.4.3.-]
|
Dihydrofolate reductase [EC:1.5.1.3]
|
DHFR [HSA:1719 200895] [KO:K00287]
|
 D00142 Methotrexate (JP17/USP/INN) <JP/US>
D02115 Methotrexate sodium <US>
D07472 Pemetrexed (INN)
D03828 Pemetrexed disodium (USAN)
D06503 Pemetrexed sodium hydrate (JAN) <JP/US>
D10596 Pemetrexed sodium hemipentahydrate (JAN)
D05589 Pralatrexate (JAN/USAN/INN) <JP/US>
D06238 Trimetrexate (USAN/INN)
D06239 Trimetrexate glucuronate (USAN)
D03942 Edatrexate (USAN/INN)
D05500 Piritrexim isethionate (USAN)
D05999 Talotrexin ammonium (USAN)
D11352 Pemetrexed tromethamine (USAN)
|
|
NAD(P)H dehydrogenase [EC:1.6.5.2]
|
Peroxidase [EC:1.11.1.-]
|
Peroxygenase [EC:1.11.2.-]
|
Dioxygenases [EC:1.13.11.-]
|
Prolyl 4-hydroxylase [EC:1.14.11.2]
|
HIF hydroxylase [EC:1.14.11.29]
|
Nitic oxide synthase [EC:1.14.13.39]
|
Cytochrome P450 [EC:1.14.14.-]
|
Other monooxygenases [EC:1.14.16.- 1.14.17.- 1.14.18.-]
|
Prostaglandin synthase [EC:1.14.99.1]
|
Superoxide dismutase [EC:1.15.1.1]
|
Xanthine dehydrogenase/oxidase [EC:1.17.1.4 1.17.3.2]
|
Ribonucleoside-diphosphate reductase [EC:1.17.4.1]
|
Vitamin-K-epoxide reductase [EC:1.17.4.4]
|
Thyroxine 5'-deiodinase [EC:1.21.99.4]
|
Transferases (EC2)
|
Methyltransferases [EC:2.1.1.-]
|
COMT [HSA:1312] [KO:K00545]
|
DNMT [HSA:1786 1788 1789] [KO:K00558 K17398 K17399]
|
DNMT1 [HSA:1786] [KO:K00558]
|
EZH [HSA:2145 2146] [KO:K17451 K11430]
|
EZH2 [HSA:2146] [KO:K11430]
|
TYMS [HSA:7298] [KO:K00560]
|
D01064 Raltitrexed (JAN/USAN/INN)
D07472 Pemetrexed (INN)
D03828 Pemetrexed disodium (USAN)
D06503 Pemetrexed sodium hydrate (JAN) <JP/US>
D10596 Pemetrexed sodium hemipentahydrate (JAN)
D00584 Fluorouracil (JP17/USP/INN) <JP/US>
D07974 Fluorouracil sodium salt
D01244 Tegafur (JP17/USAN/INN) <JP>
D01784 Carmofur (JP17/INN)
D01223 Capecitabine (JAN/USP/INN) <JP/US>
D04197 Floxuridine (USP/INN) <US>
D01309 Doxifluridine (JP17/INN) <JP>
D04964 Metesind glucuronate (USAN)
D10803 Plevitrexed (INN)
D11352 Pemetrexed tromethamine (USAN)
|
|
Acyltransferases [EC:2.3.1.-]
|
gamma-Glutamyltransferase [EC:2.3.2.2]
|
E3 ubiquitin-protein ligase [EC:2.3.2.27]
|
ATP citrate synthase [EC:2.3.3.8]
|
Hexosyltransferases [EC:2.4.1.-]
|
Pentosyltransferases [EC:2.4.2.-]
|
Alkyl/Aryl transferases [EC:2.5.1.-]
|
Aminotransferase [EC:2.6.1.-]
|
Phosphotransferase [EC:2.7.1.-]
|
DNA polymerase [EC:2.7.7.7]
|
Reverse transcriptase [EC:2.7.7.49]
|
Hydrolases (EC3)
|
Lyases (EC4)
|
Isomerases (EC5)
|
Ligases (EC6)
|
GART [EC:6.3.4.13 2.1.2.2 6.3.3.1]
|
GART [HSA:2618] [KO:K11787]
|
D07472 Pemetrexed (INN)
D03828 Pemetrexed disodium (USAN)
D06503 Pemetrexed sodium hydrate (JAN) <JP/US>
D10596 Pemetrexed sodium hemipentahydrate (JAN)
D04766 Lometrexol sodium (USAN)
D05400 Pelitrexol (USAN/INN)
D11352 Pemetrexed tromethamine (USAN)
|
|
Carbamoyl-phosphate synthase [EC:6.3.4.16]
|
Acetyl-CoA carboxylase [EC:6.4.1.2]
|
|
|
Nucleic acids
|
|
|
Not elsewhere classified
|
Target-based Classification of Drugs